JOYNTRUS

Pharmaceutical preparations for treatment of autoimmune diseases; pharmaceutical preparations for treatment of inflammatory diseases; pharmaceutical preparations for treatment of cancer; pharmaceutical preparations for treatment of rheumatoid arthritis, juvenile idiopathic arthritis, axial spondyloarthritis, psoriatic arthritis, Crohn's disease, paediatric Crohn's disease, ulcerative colitis, psoriasis, paediatric plaque psoriasis, uveitis, hidradenitis suppurativa, asthma, bronchitis, CODP, bronchial asthma, allergic rhinitis, allergic airway inflammation, allergic arthritis, Non-Hodgkin¿s lymphoma (NHL), chronic lymphocytic leukaemia (CLL), granulomatosis with polyangiitis, and microscopic polyangiitis; pharmaceutical preparations for prevention of autoimmune diseases; pharmaceutical preparations for prevention of inflammatory diseases; pharmaceutical preparations for prevention of cancer; pharmaceutical preparations for prevention of rheumatoid arthritis, juvenile idiopathic arthritis, axial spondyloarthritis, psoriatic arthritis, Crohn's disease, paediatric Crohn's disease, ulcerative colitis, psoriasis, paediatric plaque psoriasis, uveitis, hidradenitis suppurativa, asthma, bronchitis, CODP, bronchial asthma, allergic rhinitis, allergic airway inflammation, allergic arthritis, Non-Hodgkin¿s lymphoma (NHL), chronic lymphocytic leukaemia (CLL), granulomatosis with polyangiitis, and microscopic polyangiitis